SCHEMBL7707572

SCHEMBL7707572

CC(=O)ON(C1CCCCC1)C1CCCCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.39
▸ HPGD P15428 1/20 0.39
▸ ADH1A P07327 4/20 0.37
▸ ADH1C P00326 3/20 0.37
▸ HSD11B1 P28845 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.34
▸ SPHK1 Q9NYA1 2/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ NPSR1 Q6W5P4 2/20 0.34
▸ NPC1 O15118 2/20 0.34
▸ APAF1 O14727 1/20 0.34
▸ TDP2 O95551 1/20 0.34
▸ S1PR4 O95977 1/20 0.34
▸ HSP90AA1 P07900 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ PKM P14618 1/20 0.34
▸ XBP1 P17861 1/20 0.34
▸ S1PR1 P21453 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4646285 0.89 EPHX1 (0.38) TSHRHPGDADH1AADH1C
SCHEMBL973483 0.81 HSD11B1 (0.37) TSHRHPGDADH1AADH1CHSD11B1
SCHEMBL6914582 0.80 ADH1A (0.40) TSHRHPGDADH1AADH1CALDH1A1
SCHEMBL11135152 0.77 HSD11B1 (0.35) TSHRHPGDADH1AADH1CHSD11B1
SCHEMBL6932731 0.77 HSD11B1 (0.39) TSHRHPGDADH1AADH1CHSD11B1
SCHEMBL28490982 0.76 LMNA (0.40) ADH1AADH1CHSD11B1ALDH1A1KDM4E
SCHEMBL5547582 0.76 ADH1A (0.37) ADH1AADH1CHSD11B1ALDH1A1KDM4E
SCHEMBL28949799 0.72 HSD11B1 (0.35) ADH1AHSD11B1ALDH1A1KDM4ENPC1
SCHEMBL4453296 0.71 TSHR (0.42) TSHRADH1AADH1CALDH1A1KDM4E
SCHEMBL29046352 0.70 NAAA (0.57) L3MBTL1MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101039902-B Aminoalcohol derivatives ASTELLAS PHARMA INC 2010-11-10 — — CN disclosed
CN-101061092-A Niacin receptor agonists, compositions containing such compounds and methods of treatment MERCK & CO INC (US) 2007-10-24 — — CN disclosed
CN-101039902-A Aminoalcohol derivatives ASTELLAS PHARMA INC (JP) 2007-09-19 — — CN disclosed
US-6361940-B1 IMMOBILIZATION; GENETIC ENGINEERING QIAGEN GENOMICS, INC. 2002-03-26 — — US disclosed
EP-0958378-A2 COMPOSITIONS AND METHODS FOR ENHANCING HYBRIDIZATION SPECIFICITY Rapigene, Inc. (US) 1999-11-24 — — EP disclosed
EP-0952228-A2 Compositions and methods for enhancing hybridization specificity Rapigene, Inc. (US) 1999-10-27 — — EP disclosed
WO-1998013527-A2 COMPOSITIONS AND METHODS FOR ENHANCING HYBRIDIZATION SPECIFICITY RAPIGENE, INC. (US) 1998-04-02 — — WO disclosed
US-4107432-A ANTIBIOTICS MERCK & CO., INC. (US) 1978-08-15 — — US disclosed
US-4058661-A 7-Diacyl cephalosporins MERCK & CO., INC. (US) 1977-11-15 — — US disclosed
US-4014873-A Process for the production of 7-acylamidocephalosporins MERCK & CO., INC. (US) 1977-03-29 — — US disclosed
Send feedback